Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Association between FF Proximity and BMI by sex. by Kimberly Yuin Y’ng Wong (22766265)

“…An exponential decrease in FF proximity was associated with 0.7 kg/m² (p < 0.001) increase in BMI among males and 0.4 kg/m² (p < 0.05) decrease among females. …”

Average difference in mean daily exercise minutes in the week before and the week after transitioning between the indicated software versions. by Shelby L. Sturrock (10751675)

Subjects:

Average difference in mean daily active calories in the week before and the week after transitioning between the indicated software versions. by Shelby L. Sturrock (10751675)

Subjects:

The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment... by Flavia Cerasti (21655934)

Effectiveness of the proposed method to decrease chloroplast contamination. by Gabriela Madrid (11871401)

Shuffling identity decreases behavior trajectory uniqueness. by Catalin Mitelut (5587493)

IMU raw data: (a) 3-DoF accelerometer data (b) 3-DoF gyroscope data. by Saravanan Manoharan (21273304)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

A sample choice question without a warning label. by Yulian Ding (5984591)

“…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”

Intraperitoneal injection protocol for inhibitors (A), inhibitors DAS and Y27632 reduced intestinal permeability (B) and intestinal adult worm burden (C) of infected mice. by Wen Wen Zheng (17721404)

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

Subjects:

Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

Subjects: